Panacea BioMatx
Research Triangle Park, US · Founded 2013
Founders & leadership
ET
Edison Thurman HudsonNamed on SEC filing
TH
Thomas H. RobergNamed on SEC filing
JJ
Jeffrey Joseph Eshelman BournNamed on SEC filing
LS
Lloyd Staton NoelNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$267.3K disclosed across 1 round · 2014
▶$267.3KraisedApr 2014 · 16 investors · Other Health CareRule 506(b)
▶$267.3KraisedApr 2014 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Edison Thurman HudsonExecutive Officer, Director
- Thomas H. RobergDirector
- Jeffrey Joseph Eshelman BournExecutive Officer
- Lloyd Staton NoelExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $267.3K
- Minimum investment
- $2K
- Proceeds to insiders
- $50K
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Panacea BioMatx raised?
- Panacea BioMatx has disclosed $267.3K raised across 1 round.
- Where is Panacea BioMatx headquartered?
- Panacea BioMatx is headquartered in Research Triangle Park, US.